Atsushi Shinagawa

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 375 citations · Full text

Hematological Malignancy, Medicine, Hematology +6

ALK+, CD30−, CD20− Large B-Cell Lymphoma Containing Anaplastic Lymphoma Kinase (ALK) Fused to Clathrin Heavy Chain Gene (CLTC)

Norio Chikatsu, Hiroshi Kojima, Kazumi Suzukawa et al. · Modern Pathology · 2003 · 82 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Oncology +7

Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma

Tran B. Nguyen, Mamiko Sakata‐Yanagimoto, Manabu Fujisawa et al. · Cancer Research · 2020 · 53 citations

Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma

Mamiko Sakata‐Yanagimoto, Rie Nakamoto-Matsubara, Daisuke Komori et al. · Annals of Hematology · 2017 · 45 citations

Lymphoid Neoplasia, Medicine, Malignant Blood Disorder +11

Identification of a novel fusion gene <i>MLL‐MAML2</i> in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23)

Noriko Nemoto, Kazumi Suzukawa, Seiichi Shimizu et al. · Genes Chromosomes and Cancer · 2007 · 43 citations · Full text